| Androgen receptor signaling regulates DNA repair in prostate cancers WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ... Cancer discovery 3 (11), 1245-1253, 2013 | 553* | 2013 |
| Four Key Steps Control Glycolytic Flux in Mammalian Cells LB Tanner, AG Goglia, MH Wei, T Sehgal, LR Parsons, JO Park, E White, ... Cell systems 7 (1), 49-62. e8, 2018 | 349 | 2018 |
| Optogenetic control of protein binding using light-switchable nanobodies AA Gil, C Carrasco-López, L Zhu, EM Zhao, PT Ravindran, MZ Wilson, ... Nature communications 11 (1), 4044, 2020 | 129 | 2020 |
| Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells RS Bindra, AG Goglia, M Jasin, SN Powell Nucleic acids research 41 (11), e115-e115, 2013 | 101 | 2013 |
| A bright future: optogenetics to dissect the spatiotemporal control of cell behavior AG Goglia, JE Toettcher Current Opinion in Chemical Biology 48, 106-113, 2019 | 99 | 2019 |
| A live-cell screen for altered Erk dynamics reveals principles of proliferative control AG Goglia, MZ Wilson, SG Jena, J Silbert, LP Basta, D Devenport, ... Cell systems 10 (3), 240-253. e6, 2020 | 69 | 2020 |
| Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors AG Goglia, R Delsite, AN Luz, D Shahbazian, AF Salem, RK Sundaram, ... Molecular cancer therapeutics 14 (2), 326-342, 2015 | 48 | 2015 |
| Optogenetic Control of Ras/Erk Signaling Using the Phy–PIF System AG Goglia, MZ Wilson, DB DiGiorno, JE Toettcher Kinase Signaling Networks, 3-20, 2017 | 20 | 2017 |
| Four Key Steps Control Glycolytic Flux in Mammalian Cells. Cell Syst. 7, 49-62. e8 LB Tanner, AG Goglia, MH Wei, T Sehgal, LR Parsons, JO Park, E White, ... | 17 | 2018 |
| P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer L Barrio-Real, C Lopez-Haber, V Casado-Medrano, AG Goglia, ... Oncotarget 9 (47), 28612, 2018 | 15 | 2018 |
| Radiation oncology alternative payment model and large urban academic centers: Future implications for patients and providers P Pendyala, AG Goglia, R Young, JH Suh, RD Ennis JCO Oncology Practice 17 (12), e1968-e1976, 2021 | 5 | 2021 |
| Impact of the Coronavirus Disease of 2019 Pandemic on Radiation Oncology Clinical Decision Making in a High-Prevalence Environment P Pendyala, AG Goglia, MD Mattes, A Grann, D Huang, RT Wagman, ... Advances in Radiation Oncology 6 (3), 100680, 2021 | 5 | 2021 |
| Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases NA Wijetunga, AG Goglia, N Weinhold, MF Berger, M Cislo, DS Higginson, ... Clinical Cancer Research 29 (4), 775-783, 2023 | 4 | 2023 |
| Temporal arteritis and vision loss in microscopic polyangiitis: a case report and literature review AG Goglia, M Makar, C Vanuitert, V Finkelstein Case Reports in Nephrology 2020 (1), 1426401, 2020 | 4 | 2020 |
| Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors M Alshalalfa, AG Goglia, N Swami, B Nguyen, HY Hougen, A Khan, ... Urologic Oncology: Seminars and Original Investigations 41 (5), 253. e21-253 …, 2023 | 3 | 2023 |
| Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. EC Dee, AG Goglia, N Swami, B Nguyen, HY Hougen, A Khan, AU Kishan, ... Journal of Clinical Oncology 41 (16_suppl), 5067-5067, 2023 | 1 | 2023 |
| Towards ‘end-to-end’analysis and understanding of biological timecourse data SG Jena, AG Goglia, BE Engelhardt Biochemical Journal 479 (11), 1257-1263, 2022 | 1 | 2022 |
| A Proposed Way Forward From the Prior Authorization Crisis in Radiation Oncology P Pendyala, AG Goglia, RD Ennis Applied Radiation Oncology 11 (1), 7-13, 2022 | 1 | 2022 |
| Light-responsive fusion proteins for controlling binding to targets J Toettcher, J Avalos, M Wilson, A Goglia, A Gil, C Carrasco-Lopez US Patent 11,746,131, 2023 | | 2023 |
| Pan-cancer landscape of FOXA1 alterations: Insights and clinical implications. EC Dee, AG Goglia, A Khan, HY Hougen, N Swami, J Kannikal, ... Journal of Clinical Oncology 41 (16_suppl), 3090-3090, 2023 | | 2023 |
